Regulatory Risk There is a recent FDA warning letter tied to CGMP violations and distribution of contaminated eye drops, signaling heightened regulatory scrutiny. This presents an opening for sales discussions around quality assurance solutions, CGMP compliance services, and contamination control products to restore confidence and prevent future incidents.

Quality & Safety Focus OASIS emphasizes continuous improvement, accountability, and a patient care experience. Leverage this by offering advanced quality management tools, robust supplier certifications, and comprehensive safety auditing services that align with their commitment to reliable, solution-based products.

Strategic Partnerships Their model centers on long-term partnerships with eye care providers and a consultative, win-win approach. Position value propositions around deployment of scalable collaboration platforms, training programs for clinics, and revenue-enhancing patient flow optimization that strengthens partner ecosystems.

Growth Potential With revenue in the mid-range and a broad portfolio (dry eye and surgical tools) plus recent product lines and expansions, there is room to upsell with integrated device support, consumables, and data-driven outcomes analytics that improve practice efficiency and patient satisfaction.

Technology Stack OASIS already uses a mix of Salesforce, Oracle Cloud, Magento, and analytics tools. This opens opportunities to propose interoperability enhancements, CRM-led sales enablement, e-commerce for parts or accessories, and data integration services to streamline operations and improve go-to-market effectiveness.